Reports for SIVEM PHARMACEUTICALS ULC
Company Name
SIVEM PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
378 |
|
| Actual shortage: | 22 (6%) | |
| Anticipated shortage: | 9 (2%) | |
| Avoided shortage: | 14 (4%) | |
| Resolved: | 333 (88%) | |
Discontinuation Reports |
107 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 100 (93%) | |
| Reversed: | 7 (7%) | |
Late reports |
83 (17%) |
|
Overdue reports |
3 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PREGABALIN | 50MG | CAPSULE | Resolved | 2017-11-06 | 2018-01-18 | 28276 |
| PREGABALIN | 50MG | CAPSULE | Resolved | 2017-11-06 | 2017-12-23 | 28279 |
| PREGABALIN | 50MG | CAPSULE | Resolved | 2018-01-18 | 2018-06-30 | 36414 |
| PREGABALIN | 75MG | CAPSULE | Resolved | 2018-01-18 | 2018-06-30 | 36417 |
| PREGABALIN | 150MG | CAPSULE | Resolved | 2017-12-12 | 2018-01-18 | 32628 |
| PREGABALIN | 150MG | CAPSULE | Resolved | 2018-01-18 | 2018-06-30 | 36420 |
| PREGABALIN | 300MG | CAPSULE | Resolved | 2018-05-04 | 2018-05-19 | 48427 |
| PREGABALIN | 300MG | CAPSULE | Resolved | 2021-08-11 | 2021-10-19 | 143950 |
| QUETIAPINE | 25MG | TABLET | Resolved | 2019-05-13 | 2019-07-13 | 83939 |
| QUETIAPINE | 25MG | TABLET | Resolved | 2019-05-24 | 2019-07-12 | 84672 |
| QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-16 | 2019-10-12 | 93973 |
| QUETIAPINE | 25MG | TABLET | Avoided shortage | 2019-11-11 | 2019-11-18 | 98342 |
| QUETIAPINE | 100MG | TABLET | Resolved | 2019-04-09 | 2019-05-21 | 80880 |
| QUETIAPINE | 100MG | TABLET | Resolved | 2023-04-26 | 2023-08-16 | 190322 |
| QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-12-12 | 2018-03-26 | 32631 |
| QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-01-31 | 2024-04-03 | 217989 |
| QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2017-12-12 | 2018-03-26 | 32634 |
| QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-01-31 | 2024-01-31 | 217992 |
| QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-12-12 | 2018-03-26 | 32639 |
| QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-01-31 | 2024-04-03 | 217995 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53318 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53321 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53324 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53327 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-10-22 | 53330 |
| ATORVASTATIN-10 | 10MG | TABLET | Discontinued | 2019-01-03 | 2019-05-31 | 70938 |
| ATORVASTATIN-20 | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-06-10 | 70941 |
| ATORVASTATIN-40 | 40MG | TABLET | Discontinued | 2019-01-03 | 2019-07-12 | 70944 |
| ATORVASTATIN-80 | 80MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 12012 |
| ATORVASTATIN-80 | 80MG | TABLET | Discontinued | 2019-01-03 | 2019-05-22 | 70947 |
| BICALUTAMIDE | 50MG | TABLET | Discontinued | 2019-06-12 | 2019-11-30 | 86431 |
| BICALUTAMIDE | 50MG | TABLET | Discontinued | 2019-06-12 | 2020-02-21 | 86436 |
| CANDESARTAN | 4MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 12033 |
| CLONAZEPAM | 0.25MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28145 |
| CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28148 |
| CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28151 |
| CLONAZEPAM | 1MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28154 |
| CLONAZEPAM | 1MG | TABLET | Discontinued | 2017-11-06 | 2017-12-12 | 28157 |
| CLONAZEPAM | 2MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28160 |
| CLONAZEPAM | 2MG | TABLET | Discontinued | 2017-11-06 | 2017-12-12 | 28163 |